Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success

Of the 50 companies founded out of Stanford’s Biodesign center, just two have folded. Six were acquired; the rest are "alive and well." The program director shares the secrets behind…

PALO ALTO, Calif. — A series of glass cabinets lines the back wall of this Stanford building, the shelves crowded with health technologies dreamed up here. There’s a bottle of thick blue gel that helps drugs stick inside the colon, a heartbeat-tracking patch, an under-the-sheets sensor that buzzes to prevent night terrors, and a baby doll with a dozen redesigned versions of an umbilical catheter lying next to its blanket.

“My favorite thing is just looking at some of the technologies that have come out,” said Dr. Paul Yock, pointing to a low-cost substitute for the pricey ventilators found in the intensive care unit.

The shelves are a hall of fame of sorts for Yock, a cardiologist and bioengineer who runs Stanford’s

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de STAT

STAT2 min de lecture
STAT Plus: Pharmalittle: White House Signs Deal For U.S.-made Generics To Fight Covid-19; Gilead Expands Remdesivir Donations
The Trump administration signed a contract with Phlow, a new company in Richmond, Va., to make generic drugs and pharmaceutical ingredients needed to treat Covid-19.
STAT1 min de lecture
STAT Plus: Pharmalittle: Moderna Executives Cashed Out Big Time; Should We Have ‘Quality Scores’ For Manufacturing Drugs?
A group of academics and pharmacists argue that assigning scores based on a mix of regulatory actions and chemical analysis would motivate drug makers to produce more “quality” drugs.
STAT1 min de lecture
STAT Plus: Phlow CEO Speaks Out On Criticism Of His Record, Plans For A Drug Ingredient Stockpile, And A Huge Government Contract
STAT spoke with Phlow CEO Eric Edwards about the criticism over his track record, Phlow's plan to create a national drug ingredient stockpile, and the huge government contract the company…